| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.07. | Cuprina Holdings LTD - F-1, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 24.06. | Morning Market Movers: Cuprina Holdings, CEA Industries, Absci, The Wendy's Company See Big Swings | 855 | AFX News | MEMPHIS (dpa-AFX) - At 7:10 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 16.06. | Cuprina Holdings Falls 22% After 112% Rally - Here's Why CUPR Stock Is Trending | 4 | Benzinga.com | ||
| 15.06. | Cuprina erhält FDA-Zulassung für Produkt zur Madentherapie | 8 | Investing.com Deutsch | ||
| 15.06. | Cuprina receives FDA clearance for maggot wound therapy product | 1 | Investing.com | ||
| CUPRINA HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 15.06. | Cuprina Holdings (Cayman) LTD: Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots - the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product | 360 | GlobeNewswire (Europe) | SINGAPORE, June 15, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("CUPR" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 12.06. | Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements | 435 | GlobeNewswire (Europe) | SINGAPORE, June 12, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 12.06. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.05. | Cuprina requests Nasdaq hearing after delisting notice | 2 | Investing.com | ||
| 29.05. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing | 214 | GlobeNewswire (Europe) | SINGAPORE, May 29, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings Cayman Limited Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 22.05. | Cuprina to implement 1-for-8 share consolidation to address Nasdaq compliance | 1 | Seeking Alpha | ||
| 22.05. | Cuprina plant Aktienzusammenlegung im Verhältnis 1:8 zur Sicherung der NASDAQ-Notierung | 5 | Investing.com Deutsch | ||
| 22.05. | Cuprina plans 1-for-8 reverse stock split to meet Nasdaq rules | 1 | Investing.com | ||
| 22.05. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings announces 1-for-8 Share Consolidation | 395 | GlobeNewswire (Europe) | SINGAPORE, May 22, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen | |
| 14.05. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 27.04. | Cuprina Holdings LTD - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 21.04. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 11.03. | Cuprina Holdings (Cayman) LTD: Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board | 792 | GlobeNewswire (Europe) | SINGAPORE, March 11, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic... ► Artikel lesen | |
| 11.03. | Cuprina Holdings LTD - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 09.12.25 | Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth | 411 | GlobeNewswire (Europe) | SINGAPORE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CO-DIAGNOSTICS | 1,510 | 0,00 % | Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer | SALT LAKE CITY, July 16, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented... ► Artikel lesen | |
| CYTOSORBENTS | 0,324 | -4,71 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | PRINCETON, N.J., May 13, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,650 | -1,35 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| FULGENT GENETICS | 16,200 | +0,62 % | Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates | ||
| EMBECTA | 3,097 | -6,66 % | Picard Medical, Inc.: Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026 | ||
| CHECK-CAP | 0,980 | -2,00 % | Humanoid Global meldet Fortschritte von MBody AI bei der kommerziellen Expansion und dem geplanten Unternehmenszusammenschluss mit Check-Cap | Vancouver, BC / 14. Juli 2026 / IRW-Press / Humanoid Global
Holdings Corp. ("Humanoid Global" oder das "Unternehmen")
(CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), ein börsennotierter
Investment-Emittent... ► Artikel lesen | |
| MEDLINE | 31,800 | -13,11 % | Medline Inc.: Medline Reports Second Quarter and First Six Months 2026 Results | Second quarter net sales of $7.7 billion, an increase of 11.6%Second quarter net income of $139 million, a decrease of 58.3%Second quarter Adjusted EBITDA1 of $1.1 billion, an increase of 13.4%First... ► Artikel lesen | |
| ELECTROCORE | 5,200 | 0,00 % | electroCore, Inc.: electroCore Announces Full Year 2025 Financial Results and Organizational Changes | Record full year 2025 net sales of $32.0, an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general wellness... ► Artikel lesen | |
| CATHETER PRECISION | 0,264 | -7,62 % | Catheter Precision, Inc.: Flyte Partners with Volato AI to Become First Enterprise Customer, Accelerating Technology Strategy to Scale Regional Private Aviation | Enterprise Artificial Intelligence Deployment Expected to Enhance Customer Experience, Improve Operating Efficiency, and Increase Workforce Productivity Across Flight Operations Technology Strengthens... ► Artikel lesen | |
| CLEARPOINT NEURO | 12,990 | +0,89 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Second Quarter 2026 Results | Positive BioPharma Partner Regulatory Progress and Early Success in Focused Ultrasound Technology Platform Expansion SOLANA BEACH, CA / ACCESS Newswire / August 3, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen | |
| OMADA HEALTH | 17,500 | -0,57 % | Omada Health, Inc.: Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support | SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA) announced it will serve as an independent program administrator in Eli Lilly and Company's Employer Connect program. Omada... ► Artikel lesen | |
| ENVUE MEDICAL | 0,370 | +0,03 % | ENvue Medical, Inc.: ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities | TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical device company, today announced it has completed the transition... ► Artikel lesen | |
| ENDRA LIFE SCIENCES | 4,470 | +5,92 % | ASP Isotopes Inc.: ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing | Combination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Renergen's Virginia Gas Project Listing expected to provide investors with direct exposure to one of... ► Artikel lesen | |
| FIREFLY NEUROSCIENCE | 1,120 | -5,88 % | Firefly Neuroscience, Inc.: Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes | KENMORE, N.Y., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company advancing precision neuroscience... ► Artikel lesen | |
| FEMASYS | 2,920 | -4,26 % | Femasys Inc.: Femasys Regains Compliance with Nasdaq Listing Requirements | ATLANTA, June 24, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective... ► Artikel lesen |